ACCRUED EXPENSES (Tables)

9 Months Ended

Sep. 30, 2023

Payables and Accruals [Abstract]

Schedule of Accrued Liabilities [Table Text Block]

Accrued expenses consisted of the following:

	September 30, 2023		December 31, 2022
Accrued pre-clinical and clinical costs	$	1,055,116	$	2,137,317
Accrued product development costs		509,698		247,500
Accrued license costs		2,825,000		—
Accrued compensation		1,669,980		2,224,951
Accrued administrative costs		261,921		473,376
Accrued interest		1,224,066		916,108
Total	$	7,545,781	$	5,999,252